Abstract:Background: Advanced age is a primary risk factor for adverse COVID-19 outcomes, potentially attributed to immunosenescence and dysregulated inflammatory responses. In the post-pandemic era, with containment measures lifted, the elderly remain particularly susceptible, highlighting the need for intensified focus on immune health management. Methods: A total of 281 elderly patients were enrolled in this study and categorized based on their clinical status at the time of admission into three groups: non-severe (n = 212), severe survivors (n = 49), and severe non-survivors (n = 20). Binary logistic regression analysis was employed to identify independent risk factors associated with disease severity and in-hospital outcomes. The diagnostic performance of risk factors was assessed using the receiver operating characteristic (ROC) curves. Kaplan-Meier survival analysis and log-rank test were utilized to compare the 30-day survival rates. Furthermore, the transcriptomic data of CD4 + T cells were extracted from Gene Expression Omnibus (GEO) database. Gene Set Enrichment Analysis (GSEA) was applied to reveal biological processes and pathways involved. Results: In the comparison between severe and non-severe COVID-19 cases, significant elevations were observed in the neutrophil-to-lymphocyte ratio (NLR), C-reactive protein (CRP), and Serum Amyloid A (SAA) levels, concurrent with a notable reduction in CD8 + T cells, CD4 + T cells, natural killer (NK) cells, and monocytes (all p < 0.05). CD4 + T cells (OR: 0.997 [0.995-1.000], p <0.05) and NLR (OR: 1.03 [1.001-1.060], p <0.05) were independent risk factors affecting disease severity. The diagnostic accuracy for COVID-19 severity, as measured by the area under the curve (AUC) for CD4 + T cells and NLR, was 0.715 (95% CI: 0.645-0.784) and 0.741 (95% CI: 0.675-0.807), respectively. Moreover, patients with elevated NLR or IL-6 levels at admission exhibited significantly shorter survival times. Gene Set Enrichment Analysis (GSEA) revealed several biological pathways that are implicated in the regulation of immune responses and metabolic processes. Conclusions: Lymphocytopenia and the cytokine storm onset are significant predictors of an unfavorable prognosis in elderly patients. The decrease in CD4 + T cells among elderly patients is detrimental to disease recovery, and the biological pathways regulated by these cells could potentially heighten vulnerability to SARS-CoV-2 infection, thereby exacerbating the development of associated complications.

Understanding the Clinical Features of Coronavirus Disease 2019 from the Perspective of Aging: A Systematic Review and Meta-Analysis

Analysis of Epidemiological and Clinical Features in Older Patients with Coronavirus Disease 2019 (COVID-19) Outside Wuhan

COVID-19 in Elderly Adults: Clinical Features, Molecular Mechanisms, and Proposed Strategies

Clinical Characteristics and Outcomes of Older Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A Single-Centered, Retrospective Study.

Association Between Age and Clinical Characteristics and Outcomes of Coronavirus Disease 2019

Clinical characteristics and manifestations in older patients with COVID-19

Comparison of Clinical Characteristics and Outcomes of Patients with Coronavirus Disease 2019 at Different Ages

Clinical Features and Short-Term Outcomes of Elderly Patients with COVID-19

Association between age and clinical characteristics and outcomes of COVID-19

Comparison of Clinical Characteristics of COVID-19 Between Elderly Patients and Young Patients: a Study Based on a 28-Day Follow-Up

Clinical observations in the very elderly patients with COVID-19 in Wuhan.

Coronavirus Disease 2019 in Elderly Patients: Characteristics and Prognostic Factors Based on 4-Week Follow-Up.

Risk Factors for Mortality of Coronavirus Disease 2019 (COVID-19) Patients During the Early Outbreak of COVID-19: a Systematic Review and Meta-Analysis

Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients

Clinical and Imaging Features of Novel Coronavirus Pneumonia in the Elderly Compared with Young and Middle-Aged Individuals

Clinical Characteristics of Elderly Patients with COVID-19 in Hunan Province, China: A Multicenter, Retrospective Study

Immunological characteristics in elderly COVID-19 patients: a post-COVID era analysis

Clinical characteristics and prognostic factors in elderly patients with COVID-19

Clinical characteristics of 2019 novel coronavirus pneumonia and risk factors for severe cases: a meta-analysis involving 5,729 patients

Clinical characteristics of 312 hospitalized older patients with COVID-19 in Wuhan, China